Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Anne, Polk"'
Autor:
Stuhff, Michael V., Gard, Spencer A., Leaton, James C., Lynch, Michael C., Vesely, I. J., Fine, Donald I., Rubin, Sol, Smith, Bennett L., Fugit, Gerald K., Spelman, William V., Kingcade, Thomas E., Traynor, Roy T., O'Meara, Mary Anne Polk, Haupt, Bruce W., Weingarten, Stephen C., Patrick, William B., Engel, Ralph M., Miller, Ruth Loyd, Ritter, Paul, Baker, Benton, DeVane, Jerry A., Murdoch, Converse, Lowrey, Olan B., Reich, Kenneth A.
Publikováno v:
American Bar Association Journal, 1975 Feb 01. 61(2), 142-162.
Externí odkaz:
https://www.jstor.org/stable/25727048
Autor:
Ann, Banke, Anne, Polk, Dorte, Nielsen, Lars, Videbæk, Ulrik, Overgaard, Emil Loldrup, Fosbøl, Merete, Vaage-Nielsen, Kirsten Melgaard, Nielsen, Morten, Schou
Publikováno v:
Ugeskrift for laeger. 180(7)
As the prognoses of both heart and cancer patients have improved along with a longer life expectancy in the general population, the prevalence of both heart- and cancer diseases is increasing. Thus, a larger proportion of cancer patients will have ca
Publikováno v:
Cancer treatment reviews. 63
Introduction An increasing number of compounds directed against immune checkpoints are currently under clinical development. In this review we summarize current research in breast cancer. Material and methods A computer-based literature search was ca
Publikováno v:
Cancer treatment reviews. 62
Purpose Despite advances in the treatment of colorectal cancer, third-line treatment options are still limited. Regorafenib was approved in 2012 for the treatment of patients with metastatic colorectal cancer previously treated with approved standard
Publikováno v:
Acta Orthopaedica. 85:117-122
Purpose — We used patient-reported outcome and risk of revision to compare hemiarthroplasty (HA) with total shoulder arthroplasty (TSA) and stemmed hemiarthroplasty (SHA) with resurfacing hemiarthr...
Publikováno v:
Cancer Treatment Reviews. 39:974-984
Purpose To systematically review the incidence, manifestations and predisposing factors for cardiovascular toxicity in cancer patients treated with systemic 5-fluorouracil or capecitabine. Design We searched PubMed, EMBASE and Web of science for stud
Publikováno v:
Acta Orthopaedica. 84:12-17
Background and purpose Patient-reported outcome measures (PROMs) are used by some arthroplasty registries to evaluate results after surgery, but non-response may bias the results. The aim was to identify a potential bias in the outcome scores of subg
Publikováno v:
BMC Pharmacology & Toxicology
Background Cardiotoxicity is a serious side effect to treatment with 5-fluorouracil (5-FU), but the underlying mechanisms are not fully understood. The objective of this systematic review was to evaluate the pathophysiology of 5-FU- induced cardiotox
Publikováno v:
The bonejoint journal. (4)
In this study, we evaluated patient-reported outcomes, the rate of revision and the indications for revision following resurfacing hemiarthroplasty of the shoulder in patients with osteoarthritis. All patients with osteoarthritis who underwent primar
Publikováno v:
Journal of Clinical Toxicology.
Evolving evidence of cardiotoxicity in cancer patients treated with 5-fluorouracil (5-FU) has been reported. We report two different clinical manifestations of asymptomatic 5-FU-associated cardiotoxicity in patients operated for colorectal cancer and